PD-1/PD-L1 has emerged as a critical player in the pathogenesis of sepsis, and numerous treatment approaches targeting immune checkpoints have shown a promising role of targeting PD-L1 against sepsis in preclinical and clinical studies (167–169). This evidence concerns the gene PDCD1 and Sepsis.